Prosurvival and proapoptotic functions of ERK1/2 activation in murine thymocytes in vitro

被引:10
作者
Smirnova, Irina S. [1 ]
Chang, Steve [1 ]
Forsthuber, Thomas G. [1 ]
机构
[1] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA
关键词
Thymocyte; Apoptosis; Rodent; ERK; MAPK; SIGNAL-REGULATED KINASE; INDUCED APOPTOSIS; T-CELLS; CD4+CD8+ THYMOCYTES; PREVENTS APOPTOSIS; BH3-ONLY PROTEIN; PHORBOL ESTER; JURKAT CELLS; PHOSPHORYLATION; PATHWAY;
D O I
10.1016/j.cellimm.2009.10.008
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The extracellular signal-regulated kinases 1/2 (ERK1/2) are serine/threonine-selective protein kinases involved in proliferation and differentiation of cells, including thymocytes. The requirement of ERK1/2 for thymocyte differentiation and maturation has been well established; however, their role in regulating thymocyte survival and apoptosis has not been resolved. Here, we asked whether ERK1/2 affected thymocyte survival in vitro in response to apoptotic stimuli. The results show that phorbol 12-myristate 13-acetate (PMA) treatment (with or without ionomycin) and serum starvation (s/s) induced sustained ERK1/2 activation in murine thymocytes. Importantly, pharmacological treatment of thymocytes with the MEK inhibitor UO126 revealed that PMA-induced ERK1/2 activation was proapoptotic, whereas serum starvation-induced ERK1/2 activation inhibited apoptosis and promoted cell survival. While basal MEK activity was required for both s/s- and PMA-induced ERK1/2 activation, MEK activity increased only in response to PMA. The results show that the suppression of ERK1/2 phosphatases was responsible for s/s-induced sustained ERK1/2 activation. Unexpectedly, neither s/s-induced proapoptotic nor PMA-induced anti-apoptotic functions of ERK1/2 depended on the Bcl-2 family phosphoprotein Bim(EL), which was previously implicated in thymocyte apoptosis. Lastly, etoposide treatment of immature thymocytes induced both p53 and ERK1/2 activation, but ERK1/2 activity did not affect the phosphorylation and stabilization of p53. Thus, ERK1/2 has a dual role in promoting cell survival and cell death in thymocytes in the context of different stimuli. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:29 / 36
页数:8
相关论文
共 41 条
  • [1] ERK Activation and Nuclear Signaling Induced by the Loss of Cell/Matrix Adhesion Stimulates Anchorage-Independent Growth of Ovarian Cancer Cells
    A-Ayoubi, Adnan
    Tarcsafalvi, Adel
    Zheng, Hui
    Sakati, Wayne
    Eblen, Scott T.
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2008, 105 (03) : 875 - 884
  • [2] Duration of calcineurin and Erk signals regulates CD4/CD8 lineage commitment of thymocytes
    Adachi, S
    Iwata, M
    [J]. CELLULAR IMMUNOLOGY, 2002, 215 (01) : 45 - 53
  • [3] The Ras/MAPK cascade and the control of positive selection
    Alberola-Ila, J
    Hernández-Hoyos, G
    [J]. IMMUNOLOGICAL REVIEWS, 2003, 191 (01) : 79 - 96
  • [4] Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK
    Allan, LA
    Morrice, N
    Brady, S
    Magee, G
    Pathak, S
    Clarke, PR
    [J]. NATURE CELL BIOLOGY, 2003, 5 (07) : 647 - U45
  • [5] Induction of thymocyte apoptosis by Ca2+-independent protein kinase C (nPKC) activation and its regulation by calcineurin activation
    Asada, A
    Zhao, Y
    Kondo, S
    Iwata, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (43) : 28392 - 28398
  • [6] MEK activity regulates negative selection of immature CD4+CD8+ thymocytes
    Bommhardt, U
    Scheuring, Y
    Bickel, C
    Zamoyska, R
    Hünig, T
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (05) : 2326 - 2337
  • [7] Proapoptotic Bcl-2 relative bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity
    Bouillet, P
    Metcalf, D
    Huang, DCS
    Tarlinton, DM
    Kay, TWH
    Köntgen, F
    Adams, JM
    Strasser, A
    [J]. SCIENCE, 1999, 286 (5445) : 1735 - 1738
  • [8] THYMOCYTE APOPTOSIS INDUCED BY P53-DEPENDENT AND INDEPENDENT PATHWAYS
    CLARKE, AR
    PURDIE, CA
    HARRISON, DJ
    MORRIS, RG
    BIRD, CC
    HOOPER, ML
    WYLLIE, AH
    [J]. NATURE, 1993, 362 (6423) : 849 - 852
  • [9] COHEN GM, 1993, J IMMUNOL, V151, P566
  • [10] COHEN JJ, 1984, J IMMUNOL, V132, P38